3,016
Views
27
CrossRef citations to date
0
Altmetric
Review

Exploring the zoonotic potential of animal prion diseases

In vivo and in vitro approaches

, &
Pages 85-91 | Received 04 Dec 2013, Accepted 05 Feb 2014, Published online: 18 Feb 2014
 

Abstract

Following the discovery of a causal link between bovine spongiform encephalopathy (BSE) in cattle and variant Creutzfeldt–Jakob disease (vCJD) in humans, several experimental approaches have been used to try to assess the potential risk of transmission of other animal transmissible spongiform encephalopathies (TSEs) to humans. Experimental challenge of non-human primates, humanised transgenic mice and cell-free conversion systems have all been used as models to explore the susceptibility of humans to animal TSEs. In this review we compare and contrast in vivo and in vitro evidence of the zoonotic risk to humans from sheep, cattle and deer prions, focusing primarily on chronic wasting disease and our own recent studies using protein misfolding cyclic amplification.

10.4161/pri.28124

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Funding

Funding for this research was provided by (1) English Department of Health and the Scottish Government , Grant reference number: 007/0190 and (2)Centre for Clinical Brain Science (CCBS), The University of Edinburgh. UK.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.